Information Library
Results for: Business transformation - The New Health
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
FSPs: Ranging from Tactical to Strategic Models
White Paper — January 4, 2012
Biopharma companies can choose from a range of outsourcing models as they seek to respond effectively to the ever-changing conditions in the New Health. -
Market Intelligence - When There's No Room for Error Fact Sheet
Brochure — November 17, 2011
In the world of biopharmaceutical development, market researchers are in the hot seat. Crucial decisions hinge on research results more than ever, and each decision must be made even faster to have real impact. -
Partnering to Maximize Rewards in Pharmerging Markets
White Paper — September 15, 2011
In the past few years so-called “pharmerging” markets have been heralded as the hottest growth area for biopharmaceutical drugs. With large populations, growing disposable income and unmet medical needs, these markets have seen doubledigit growth rates in pharmaceutical spending. -
The New Health Alliance
White Paper — January 10, 2011
Biopharmaceutical companies must explore alternative strategic alliances that meet the needs of the New Health and produce medicines that demonstrate value to the entire constellation of stakeholders. -
THE NEW HEALTH REPORT FINDS GREATER INFLUENCE FOR PATIENTS ON DRUG DEVELOPMENT
Press Release — June 15, 2010 - Patients are emerging as an increasingly strong group when it comes to influencing the success and failure of new drugs – according to a newly published New Health Report commissioned by Quintiles.
-
THE NEW HEALTH REPORT REVEALS PERCEPTION GAPS AMONG BIOPHARMA STAKEHOLDERS
Press Release — June 15, 2010 - Newly published report details the differences between bio pharma and other key stakeholders as they grapple with industry challenges.
-
Navigating Risk and Seizing Opportunity in the New Health
Brochure — February 18, 2010
The bio pharma landscape has changed. Quintiles is helping bio and pharmaceutical companies navigate the way.
Page 1 of 1 (7 results)
